These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 21604821)

  • 1. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
    Ungar WJ
    Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
    Prosser LA; Hammitt JK; Keren R
    Pharmacoeconomics; 2007; 25(9):713-26. PubMed ID: 17803331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choices.
    Wolstenholme JL; Bargo D; Wang K; Harnden A; Räisänen U; Abel L
    Qual Life Res; 2018 Jul; 27(7):1769-1780. PubMed ID: 29564713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health state values for use in the economic evaluation of treatments for Alzheimer's disease.
    Shearer J; Green C; Ritchie CW; Zajicek JP
    Drugs Aging; 2012 Jan; 29(1):31-43. PubMed ID: 22191721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.
    McGrath C; Rofail D; Gargon E; Abetz L
    Health Qual Life Outcomes; 2010 Feb; 8():23. PubMed ID: 20152041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.
    Rankin J; Rowen D; Howe A; Cleland JGF; Whitty JA
    Heart Fail Rev; 2019 Jul; 24(4):549-563. PubMed ID: 30903357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods.
    Ratcliffe J; Couzner L; Flynn T; Sawyer M; Stevens K; Brazier J; Burgess L
    Appl Health Econ Health Policy; 2011; 9(1):15-27. PubMed ID: 21033766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review and Meta-analysis of Childhood Health Utilities.
    Kwon J; Kim SW; Ungar WJ; Tsiplova K; Madan J; Petrou S
    Med Decis Making; 2018 Apr; 38(3):277-305. PubMed ID: 28990449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mind the (inter-rater) gap. An investigation of self-reported versus proxy-reported assessments in the derivation of childhood utility values for economic evaluation: A systematic review.
    Khadka J; Kwon J; Petrou S; Lancsar E; Ratcliffe J
    Soc Sci Med; 2019 Nov; 240():112543. PubMed ID: 31586777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.
    Scuffham PA; Whitty JA; Mitchell A; Viney R
    Pharmacoeconomics; 2008; 26(4):297-310. PubMed ID: 18370565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of health utilities across conditions common in paediatric and adult populations.
    Tarride JE; Burke N; Bischof M; Hopkins RB; Goeree L; Campbell K; Xie F; O'Reilly D; Goeree R
    Health Qual Life Outcomes; 2010 Jan; 8():12. PubMed ID: 20105304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring health-related quality of life for child maltreatment: a systematic literature review.
    Prosser LA; Corso PS
    Health Qual Life Outcomes; 2007 Jul; 5():42. PubMed ID: 17634122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Think of the Children: A Discussion of the Rationale for and Implications of the Perspective Used for EQ-5D-Y Health State Valuation.
    Lipman SA; Reckers-Droog VT; Kreimeier S
    Value Health; 2021 Jul; 24(7):976-982. PubMed ID: 34243841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.
    Herdman M; Cole A; Hoyle CK; Coles V; Carroll S; Devlin N
    Value Health; 2016; 19(2):255-66. PubMed ID: 27021761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations.
    Matza LS; Stewart KD; Lloyd AJ; Rowen D; Brazier JE
    Value Health; 2021 Jun; 24(6):812-821. PubMed ID: 34119079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values.
    Shah KK; Ramos-Goñi JM; Kreimeier S; Devlin NJ
    Eur J Health Econ; 2020 Sep; 21(7):1091-1103. PubMed ID: 32506281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic methodological review of health state values in glaucoma cost-utility analyses.
    Kennedy K; Sarohia G; Podbielski D; Pickard S; Tarride JE; Xie F
    Eur J Health Econ; 2024 Nov; 25(8):1417-1435. PubMed ID: 38411844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.